Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies

Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies

Background: Recent randomized controlled trials have demonstrated that immune checkpoint inhibitors (ICIs) improve patient outcomes, but whether these novel agents are cost-effective for untreated advanced renal cell carcinoma (aRCC) remains unclear.Materials and Methods: A microsimulation model was...

Full description

Bibliographic Details
Main Authors:	SiNi Li, JianHe Li, LiuBao Peng, YaMin Li, XiaoMin Wan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Pharmacology
Subjects:	cost-effectiveness renal cell carcinoma microsimulation immune checkpoint inhibitors immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.718014/full

Similar Items

Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
by: SiNi Li, et al.
Published: (2021-05-01)

Novel immunotherapy in metastatic renal cell carcinoma
by: Yang Hyun Cho, et al.
Published: (2017-07-01)

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
by: Brian I. Rini, et al.
Published: (2019-12-01)

Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy
by: Hiromichi Nakajima, et al.
Published: (2021-01-01)

Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer
by: Haoyang LI, et al.
Published: (2021-02-01)

Real-world data of second-line immunotherapy in metastatic clear cell renal cell carcinoma: A retrospective study
by: Waseem Abbas, et al.
Published: (2021-01-01)

Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01)

Immunotherapy in Renal Cell Carcinoma: The Future Is Now
by: Antoine Deleuze, et al.
Published: (2020-04-01)

Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer
by: Shouzheng WANG, et al.
Published: (2016-10-01)

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
by: Lili Mao, et al.
Published: (2021-06-01)

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
by: Rohan Garje, et al.
Published: (2020-01-01)

Immunotherapy in Prostate Cancer
by: Emily K. Fay, et al.
Published: (2020-07-01)

Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives
by: Mikołaj Wołącewicz, et al.
Published: (2020-05-01)

Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor
by: Hanping WANG, et al.
Published: (2019-10-01)

Use of glucocorticoids in the management of immunotherapy‐related adverse effects
by: Hanping Wang, et al.
Published: (2020-10-01)

Immunotherapy for Uterine Cervical Cancer
by: Masahiro Kagabu, et al.
Published: (2019-09-01)

The Intriguing History of Cancer Immunotherapy
by: Paula Dobosz, et al.
Published: (2019-12-01)

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma
by: Asim Amin, et al.
Published: (2019-01-01)

Present and future perspectives on immunotherapy for advanced renal cell carcinoma: Going to the core or beating around the bush?
by: Hidenori Kawashima, et al.
Published: (2015-03-01)

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma
by: Inamura K, et al.
Published: (2019-07-01)

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
by: Izabela Karwacka, et al.
Published: (2021-01-01)

Update on immunotherapy for renal cancer
by: Rodrigo Canales Rojas
Published: (2021-06-01)

Advancing to the era of cancer immunotherapy
by: Yun Wang, et al.
Published: (2021-09-01)

Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives
by: Cesar E Ochoa, et al.
Published: (2018-02-01)

Cryoablation and immunotherapy: an overview of evidence on its synergy
by: B. M. Aarts, et al.
Published: (2019-05-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
by: Hanping Wang, et al.
Published: (2020-01-01)

Immunotherapy in patients with cervical cancer
by: A. G. Kedrova
Published: (2020-11-01)

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
by: Dietrich B, et al.
Published: (2018-01-01)

Immunotherapy in urothelial cancer: recent data and perspectives
by: M. I. Volkova, et al.
Published: (2018-01-01)

Cancer immunotherapy: Pros, cons and beyond
by: Shuzhen Tan, et al.
Published: (2020-04-01)

Recent advances in triple negative breast cancer: the immunotherapy era
by: Antonio Marra, et al.
Published: (2019-05-01)

Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
by: Lisa B.E. Shields, et al.
Published: (2021-07-01)

Perspectives on the clinical development of immunotherapy in prostate cancer
by: Lisa M Cordes, et al.
Published: (2018-01-01)

Immunotherapy in cholangiocarcinoma: From concept to clinical trials
by: Wen-Yan Yao, et al.
Published: (2021-06-01)

VISTA: A Promising Target for Cancer Immunotherapy?
by: Tagliamento M, et al.
Published: (2021-06-01)

Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects
by: B. Ya. Alekseev, et al.
Published: (2020-11-01)

The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01)

A Reflection of the New Wave of Immunotherapy on the Clinical Study of  Chinese Lung Cancer Immunotherapy
by: Jingjing LIU, et al.
Published: (2017-10-01)

Immunology and Immunotherapeutic Approaches for Advanced Renal Cell Carcinoma: A Comprehensive Review
by: Yoon-Soo Hah, et al.
Published: (2021-04-01)

Application of Immunotherapy in Hepatocellular Carcinoma
by: Lele Miao, et al.
Published: (2021-08-01)